Naturland Holding PLC Logo

Naturland Holding PLC

A Hungarian company providing full-scale pharmaceutical manufacturing from R&D to sales.

NATUR | BUD

Overview

Corporate Details

ISIN(s):
HU0000199740
LEI:
Country:
United Kingdom
Address:
N/A
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Naturland Holding PLC is a Hungarian company engaged in the full scale of pharmaceutical manufacturing. Its activities encompass research and development, product licensing, production, and sales of pharmaceutical products. The company operates through its subsidiaries to develop and bring its products to market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-31 12:04
Declaration of Voting Results & Voting Rights Announcements
Szavazati jogok, alaptőke
Hungarian 148.4 KB
2025-09-30 12:33
Declaration of Voting Results & Voting Rights Announcements
Szavazati jogok, alaptőke
Hungarian 148.3 KB
2025-09-25 17:34
Interim Report
Féléves jelentés
Hungarian 4.7 MB
2025-09-01 14:33
Declaration of Voting Results & Voting Rights Announcements
Szavazati jogok, alaptőke
Hungarian 148.4 KB

Automate Your Workflow. Get a real-time feed of all Naturland Holding PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Naturland Holding PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Naturland Holding PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ARROWHEAD PHARMACEUTICALS, INC. Logo
Develops RNAi medicines to silence genes causing intractable cardiometabolic and pulmonary diseases.
United States of America
ARWR
ARS Pharmaceuticals, Inc. Logo
Develops the first FDA-approved, needle-free epinephrine spray for severe allergic reactions.
United States of America
SPRY
ARTELO BIOSCIENCES, INC. Logo
Develops lipid-signaling therapeutics for cancer, pain, anxiety, and depression.
United States of America
ARTL
Artiva Biotherapeutics, Inc. Logo
Develops allogeneic, off-the-shelf NK cell therapies for cancer and autoimmune diseases.
United States of America
ARTV
Ascelia Pharma Logo
Develops novel drugs for rare oncology, including an oral MRI contrast agent for cancer patients.
Sweden
ACE
Ascendis Pharma A/S Logo
Biopharma using proprietary TransCon® tech to develop therapies for rare diseases & oncology.
United States of America
ASND
ASCENTAGE PHARMA GROUP INTERNATIONAL Logo
Biopharma developing small-molecule drugs for cancer, HBV, and age-related diseases.
United States of America
AAPG
Specializes in hormone drugs for OB/GYN, urology, internal medicine, and animal health.
Japan
4886
Aspire Biopharma Holdings, Inc. Logo
Developing a nano-platform for rapid, sublingual delivery of reformulated medications.
United States of America
ASBP
ASSEMBLY BIOSCIENCES, INC. Logo
Clinical-stage biopharma developing small-molecule antivirals for herpes, HBV, and HDV.
United States of America
ASMB

Talk to a Data Expert

Have a question? We'll get back to you promptly.